SCHEMBL8698384

SCHEMBL8698384

CCCCC(CCC(C)C)O[C]=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3034854 0.89 DNM1 (0.35) CTSK
SCHEMBL3040375 0.88 TRPM8 (0.30)
SCHEMBL8697461 0.85 MAPT (0.38)
SCHEMBL3034650 0.85 CTSK (0.36) CTSK
SCHEMBL3037264 0.84 CTSK (0.41) CTSK
SCHEMBL7564444 0.84
SCHEMBL9777154 0.83 MAPT (0.39)
SCHEMBL4138235 0.81 TSHR (0.37) CTSK
SCHEMBL8371036 0.81 MAPT (0.42)
SCHEMBL22342663 0.81 MAPT (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5834460-A FOR TREATMENT OF BRAIN OR PSYCHOLOGICAL DISORDERS, ALZHEIMER*S DISEASE, MENTAL RETARDATION OR AUTISM YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1998-11-10 US disclosed
EP-0696586-A1 SERINE DERIVATIVE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1996-02-14 EP disclosed
US-5453514-A Diabetes YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1995-09-26 US disclosed